Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04701684 · ClinicalTrials.gov registry record · NA
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
A NA study of Stroke, Acute, sponsored by Philips Clinical & Medical Affairs Global.
- Recruiting
- Registry status
- NA
- Development phase
- 594
- Enrollment target
- 20
- Study locations
NCT04701684: Recruiting NA study of Stroke, Acute, sponsored by Philips Clinical & Medical Affairs Global.
NCT04701684 is a NA study of Stroke, Acute that is actively recruiting participants, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 594 participants, roughly in line with the 606-participant average among 25 other Stroke, Acute trials with a reported enrollment target. The trial reports 20 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04701684, a NA study of Stroke, Acute, is actively recruiting participants, sponsored by Philips Clinical & Medical Affairs Global.
- RECRUITING
- Registry status
- NA
- Development phase
- 594 participants
- Enrollment target
- 20
- Study locations
Study Summary
The WE-TRUST study is a multi-center randomized clinical trial to assess the impact of a Direct to Angio Suite (DTAS) workflow on stroke patient outcomes.
Primary Outcome
The difference in the distribution of ordinal modified Rankin Scale (mRS) scores at 90 ± 14 days follow-up in the Target population to determine the performance of the DTAS triage imaging workflow involving Stroke CBCT reconstructions by the investigational device or SmartCT R3 in comparison to the conventional CT/MR triage imaging workflow. The 90 day mRS score will be evaluated by a blinded assessor of a pool of blinded assessors (i.e., a specialist with mRS certification) at the local hospita
Conditions Studied
Interventions
- DEVICE Direct to Angio Suite (DTAS) Philips' CBCT triage
- PROCEDURE Conventional CT/MR triage
Study Locations (20)
Other
- La Sagrada Familia Clinic - José Hernández
- UZ Brussels - Brussels
- Hospital Geral de Fortaleza - Fortaleza
- Hospital de Base - São José do Rio Preto
- Hospital Estadual Central - Fundação Estadual de Inovação em Saúde - Inova Capixaba - Vitória
- Hospices Civils de Lyon - Lyon
- CHU Montpellier - Montpellier
- Bicêtre Hospital - Paris
- University Hospital Bonn (UKB Universitätsklinikum Bonn) - Bonn
- Klinikum Kassel - Kassel
- Universitätsklinikum Schleswig-Holstein Lübeck - Lübeck
- Klinikum rechts der Isar der TU München - Munich
- St. Antonius Ziekenhuis - Nieuwegein
- Haaglanden Medical Center - The Hague
- University Emergency Hospital Bucharest - Bucharest
- Vall d'Hebron University Hospital - Barcelona
Florida
- Baptist Medical Center - Jacksonville
Georgia
- Grady Memorial Hospital/Emory University - Atlanta
New York
- Montefiore Medical Center - The Bronx
Moncloa - Aravaca
- Hospital Clinico San Carlos - Madrid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 594 participants |
| Start Date | 2021-06-23 |
| Est. Completion | 2027-04-01 |
| Phase | NA |
What NCT04701684 shows while recruiting
NCT04701684 is an interventional study that assigns participants to a tested intervention. The registered 594 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 606-participant average among 25 other Stroke, Acute trials with a reported enrollment target.
The record links to 1 condition, with Stroke, Acute appearing as the primary indexed condition, and to 2 interventions - of which Direct to Angio Suite (DTAS) Philips' CBCT triage is the first listed.
NCT04701684 names 20 study sites across 5 states, led by Other, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT04701684 about?
NCT04701684 is a clinical study titled "WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)". The WE-TRUST study is a multi-center randomized clinical trial to assess the impact of a Direct to Angio Suite (DTAS) workflow on stroke patient outcomes.
What is the current status of trial NCT04701684?
This trial is currently recruiting. It is a NA study. The enrollment target is 594 participants. The study started on 2021-06-23. Estimated completion is 2027-04-01.
What conditions does trial NCT04701684 study?
This clinical trial studies the following conditions: Stroke, Acute.
What interventions are being tested in trial NCT04701684?
The interventions under investigation include: Direct to Angio Suite (DTAS) Philips' CBCT triage (DEVICE), Conventional CT/MR triage (PROCEDURE).
Who is sponsoring clinical trial NCT04701684?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04701684 being conducted?
This trial has 20 study locations across Florida, Georgia, New York, Moncloa - Aravaca. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke, Acute
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04701684's enrollment target sits among peer trials
594 7th of 25 higher than 19 of 25 other Stroke, Acute trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke, Acute trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
RECRUITING · NA
-
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
RECRUITING · NA
-
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
RECRUITING · NA
-
Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)
RECRUITING · NA
-
ECMO ABI Detection With Hyperfine
RECRUITING · NA
-
EnDOvascular Therapy for Late WiNdow IschEmic Stroke Patients Selected bY AutoMatic Plain ComputErized Tomography
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491213 · 594 participants · NA
TELESCOPE- TELEhealth Shared Decision-making COaching
- NCT05867420 · 594 participants · Phase 1
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
- NCT06890884 · 594 participants · Phase 2
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
- NCT06892548 · 594 participants · Phase 1
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI